Admed Overseas Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-06-2024
- Paid Up Capital ₹ 0.10 M
as on 16-06-2024
- Company Age 17 Year, 6 Days
- Last Filing with ROC 31 Mar 2023
- Revenue -24.39%
(FY 2023)
- Profit -137.50%
(FY 2023)
- Ebitda 12.16%
(FY 2023)
- Net Worth -0.90%
(FY 2023)
- Total Assets -0.78%
(FY 2023)
About Admed Overseas
The Corporate was formerly known as Core Medilab Private Limited. The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vikas Goel, Gourov, Mayank Goel, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232DL2007PTC171419
- Company No.
171419
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Dec 2007
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Admed Overseas?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mayank Goel  | Additional Director | 28-Apr-2023 | Current |
| Vikas Goel | Director | 13-Dec-2007 | Current |
| Gourov | Additional Director | 13-Jul-2023 | Current |
| Gyanesh Jeswal | Director | 13-Dec-2007 | Current |
Financial Performance and Corporate Structure Insights of Admed Overseas.
Admed Overseas Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.39% decrease. The company also saw a substantial fall in profitability, with a 137.5% decrease in profit. The company's net worth dipped by a decrease of 0.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Admed Overseas?
In 2023, Admed Overseas had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Warner (India) Pharma Private LimitedActive 17 years 6 days
Mayank Goel and Gyanesh Jeswal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Admed Overseas?
Unlock and access historical data on people associated with Admed Overseas, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Admed Overseas, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Admed Overseas's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
